Ursolic acid inhibits epithelial-mesenchymal transition <i>in vitro</i> and <i>in vivo</i>

Abstract

UA attenuated renal tubulointerstitial fibrosis by inhibiting EMT, and such inhibition may be achieved by decreasing profibrotic factors. UA may be a novel therapeutic agent for renal fibrosis.